We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

199 hedge funds and large institutions have $3.17B invested in Momenta Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 79 increasing their positions, 53 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,765% more call options, than puts

Call options by funds: $20.6M | Put options by funds: $1.11M

143% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 21

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

49% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 53

36% more capital invested

Capital invested by funds: $2.33B → $3.17B (+$840M)

17% more funds holding

Funds holding: 170 → 199 (+29)

Holders
199
Holders Change
+29
Holders Change %
+17.06%
% of All Funds
4.38%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
51
Increased
79
Reduced
53
Closed
21
Calls
$20.6M
Puts
$1.11M
Net Calls
+$19.5M
Net Calls Change
+$15.4M

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$60.4M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$59M
3
RG
Redmile Group
California
+$53.9M
4
RCM
RA Capital Management
Massachusetts
+$30.2M
5
BlackRock
BlackRock
New York
+$26M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$78.1M
2
Primecap Management
Primecap Management
California
-$65.7M
3
FCM
Farallon Capital Management
California
-$53.1M
4
GPP
Great Point Partners
Connecticut
-$50.4M
5
CCM
Camber Capital Management
Massachusetts
-$34.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
76
AQR Capital Management
Connecticut
$2.83M +$2.43M +87,211 +515%
Ensign Peak Advisors
77
Ensign Peak Advisors
Utah
$2.83M +$601K +21,600 +26%
First Trust Advisors
78
First Trust Advisors
Illinois
$2.73M +$2.8M +100,478 New
SOADOR
79
State of Alaska Department of Revenue
Alaska
$2.73M +$403K +14,469 +17%
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
$2.7M +$2.77M +99,372 New
LCM
81
Laurion Capital Management
New York
$2.69M -$849K -30,500 -24%
CM
82
Caption Management
Oklahoma
$2.68M +$2.75M +98,640 New
TPSF
83
Texas Permanent School Fund
Texas
$2.63M +$529K +18,999 +24%
TCM
84
Tekla Capital Management
Massachusetts
$2.48M +$2.54M +91,316 New
Balyasny Asset Management
85
Balyasny Asset Management
Illinois
$2.48M +$529K +19,017 +26%
TD Asset Management
86
TD Asset Management
Ontario, Canada
$2.43M +$123K +4,400 +5%
New York State Common Retirement Fund
87
New York State Common Retirement Fund
New York
$2.41M – – –
Voloridge Investment Management
88
Voloridge Investment Management
Florida
$2.27M +$856K +30,740 +59%
ACM
89
Asymmetry Capital Management
California
$2.26M +$571K +20,502 +33%
CS
90
Credit Suisse
Switzerland
$2.23M +$318K +11,427 +16%
AIG
91
American International Group
New York
$2.12M +$152K +5,462 +8%
AL
92
AJO LP
Pennsylvania
$2.07M +$2.12M +76,189 New
State of Tennessee, Department of Treasury
93
State of Tennessee, Department of Treasury
Tennessee
$1.97M +$265K +9,519 +15%
Manulife (Manufacturers Life Insurance)
94
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.92M +$307K +11,034 +19%
LCG
95
Lisanti Capital Growth
New York
$1.84M +$1.88M +67,500 New
BG
96
Bellevue Group
Switzerland
$1.83M -$2.64M -95,000 -58%
Fisher Asset Management
97
Fisher Asset Management
Washington
$1.82M -$190K -6,842 -9%
Man Group
98
Man Group
United Kingdom
$1.71M -$2.38M -85,432 -58%
Deutsche Bank
99
Deutsche Bank
Germany
$1.67M -$3.09M -111,106 -64%
MSL
100
Mackay Shields LLC
New York
$1.67M -$791K -28,400 -32%
2 3
4
5 6

MNTA Hedge Fund Activity: Q1 2020 in Review

199 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q1 2020, worth a combined $3.17B — up 36% from $2.33B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new MNTA positions and 21 closed out — a net gain of 30 holders — while 79 added to existing stakes and 53 trimmed.

The largest buyer was Maverick Capital, opening a new position worth an estimated $60.4M. The largest seller was Perceptive Advisors, cutting an estimated $78.1M.

  • 199 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q1 2020, up from 170 in Q4 2019.
  • Funds reported $3.17B of Momenta Pharmaceuticals, Inc. stock for Q1 2020, up 36% quarter-over-quarter.
  • 51 funds opened new Momenta Pharmaceuticals, Inc. positions in Q1 2020 and 21 closed out, a net change of +30 holders.
  • The largest Momenta Pharmaceuticals, Inc. buyer in Q1 2020 was Maverick Capital, an estimated $60.4M added.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q1 2020 was Perceptive Advisors, an estimated $78.1M sold.

Based on aggregated 13F filings for Q1 2020.